{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"C-Reactive Protein and CV Risk in the General Population","description":" Inflammation is a key contributor to cardiovascular disease (CVD), influencing both its onset and progression. High-sensitivity C-reactive protein (hsCRP) serves as a reliable biomarker for detecting systemic inflammation and assessing cardiovascular risk. Recognizing the role of inflammation helps refine risk stratification and guide preventive strategies in the general population.&amp;nbsp;  &amp;nbsp;  In this interview, Nanette Kass Wenger MD, MACC and Prof. Dr. Florian Kahles, MD discuss \u201cC-Reactive Protein and CV Risk in the General Population\u201d.&amp;nbsp;    &amp;nbsp;SUGGESTED MATERIALS:&amp;nbsp;     Amezcua-Castillo E, Gonz\u00e1lez-Pacheco H,&amp;nbsp;S\u00e1enz-San Mart\u00edn A, et al.&amp;nbsp;C-Reactive Protein: The Quintessential Marker of Systemic Inflammation in Coronary Artery Disease-Advancing toward Precision Medicine.\u202fBiomedicines. 2023;11(9):2444. Published&amp;nbsp;2023&amp;nbsp;Sep 2. doi:10.3390\/biomedicines11092444&amp;nbsp;&amp;nbsp;      &amp;nbsp;Subscribe on Apple&amp;nbsp;Podcasts&amp;nbsp;|&amp;nbsp;Subscribe to ACCEL&amp;nbsp;  ","author_name":"ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research","author_url":"http:\/\/accelaccorg.libsyn.com\/website","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/39222405\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/196040290"}